These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3110070)

  • 21. A simple and reliable method for rapid production and purification of Pseudomonas aeruginosa haemolytic phospholipase C.
    Dubouix A; Nieto M; Fauvel J; Chap H; Marty N; Salles JP; Gaits F
    Lett Appl Microbiol; 2004; 38(3):191-6. PubMed ID: 14962039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzymatic and toxinogenic activity of culture filtrates of high and low virulent strains of Pseudomonas aeruginosa on mice.
    Muszyński Z
    Pathol Microbiol (Basel); 1973; 39(2):135-47. PubMed ID: 4267971
    [No Abstract]   [Full Text] [Related]  

  • 23. Phospholipase C: molecular biology and contribution to the pathogenesis of Pseudomonas aeruginosa.
    Vasil ML; Graham LM; Ostroff RM; Shortridge VD; Vasil AI
    Antibiot Chemother (1971); 1991; 44():34-47. PubMed ID: 1801644
    [No Abstract]   [Full Text] [Related]  

  • 24. A novel class of microbial phosphocholine-specific phospholipases C.
    Stonehouse MJ; Cota-Gomez A; Parker SK; Martin WE; Hankin JA; Murphy RC; Chen W; Lim KB; Hackett M; Vasil AI; Vasil ML
    Mol Microbiol; 2002 Nov; 46(3):661-76. PubMed ID: 12410824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Partial purification and some properties of a phospholipase C from Pseudomonas sp. strain KS3.2.
    Sugimori D; Nakamura M
    Biosci Biotechnol Biochem; 2006 Feb; 70(2):535-7. PubMed ID: 16495676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of virulence factors of pseudomonas aeruginosa by subinhibitory concentrations of quaternary ammonium salts.
    Majtán V; Hostacká A; Mlynarcik D; Devínsky F
    Arzneimittelforschung; 1995 Mar; 45(3):327-30. PubMed ID: 7741795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and some properties of Aeromonas hydrophila hemolysin.
    Asao T; Kinoshita Y; Kozaki S; Uemura T; Sakaguchi G
    Infect Immun; 1984 Oct; 46(1):122-7. PubMed ID: 6480102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzymic and permeability activity of Pseudomonas aeruginosa after treatment with sub-MICs of organic ammonium salts.
    Hostacká A; Majtán V
    Folia Microbiol (Praha); 1994; 39(3):197-202. PubMed ID: 7995601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudomonas aeruginosa hemolytic phospholipase C suppresses neutrophil respiratory burst activity.
    Terada LS; Johansen KA; Nowbar S; Vasil AI; Vasil ML
    Infect Immun; 1999 May; 67(5):2371-6. PubMed ID: 10225897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental infection with Pseudomonas aeruginosa in mice. I. The virulence of Pseudomonas aeruginosa for mice.
    Kobayashi F
    Jpn J Microbiol; 1971 Jul; 15(4):295-300. PubMed ID: 4330067
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization of phospholipase C from Pseudomonas aeruginosa as a potent inflammatory agent.
    Meyers DJ; Berk RS
    Infect Immun; 1990 Mar; 58(3):659-66. PubMed ID: 2106492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active and inactive forms of hemolysin (HlyA) from Escherichia coli.
    Wagner W; Kuhn M; Goebel W
    Biol Chem Hoppe Seyler; 1988 Jan; 369(1):39-46. PubMed ID: 3279976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceramidase enhances phospholipase C-induced hemolysis by Pseudomonas aeruginosa.
    Okino N; Ito M
    J Biol Chem; 2007 Mar; 282(9):6021-30. PubMed ID: 17202150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization of mutants affected in the osmoprotectant-dependent induction of phospholipase C in Pseudomonas aeruginosa PAO1.
    Sage AE; Vasil AI; Vasil ML
    Mol Microbiol; 1997 Jan; 23(1):43-56. PubMed ID: 9004219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudomonas keratitis: protease IV gene conservation, distribution, and production relative to virulence and other Pseudomonas proteases.
    Caballero A; Thibodeaux B; Marquart M; Traidej M; O'Callaghan R
    Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):522-30. PubMed ID: 14744894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ferrisiderophore reductases of Pseudomonas. Purification, properties and cellular location of the Pseudomonas aeruginosa ferripyoverdine reductase.
    Hallé F; Meyer JM
    Eur J Biochem; 1992 Oct; 209(2):613-20. PubMed ID: 1330553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion.
    Kadurugamuwa JL; Beveridge TJ
    J Bacteriol; 1995 Jul; 177(14):3998-4008. PubMed ID: 7608073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet aggregation by a phospholipase C from Pseudomonas aeruginosa.
    Coutinho IR; Berk RS; Mammen E
    Thromb Res; 1988 Sep; 51(5):495-505. PubMed ID: 3140410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. 3. Identity of the lethal toxins produced in vitro and in vivo.
    Liu PV
    J Infect Dis; 1966 Oct; 116(4):481-9. PubMed ID: 4959184
    [No Abstract]   [Full Text] [Related]  

  • 40. Induction of inflammatory mediator release (12-hydroxyeicosatetraenoic acid) from human platelets by Pseudomonas aeruginosa.
    König B; Jaeger KE; König W
    Int Arch Allergy Immunol; 1994 May; 104(1):33-41. PubMed ID: 7950403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.